GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline, brain atrophy due to neuronal and synapse loss, and formation of two pathological lesions: extracellular amyloid plaques, composed largely of amyloid-beta peptide (Aβ), and neurofibrillary tangles...
Autores Principales: | , , , |
---|---|
Otros Autores: | |
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | http://repository.urosario.edu.co/handle/10336/19571 https://doi.org/10.3389/fncel.2014.00167 |